Targeting CD56 with an antibody-drug conjugate in Merkel cell carcinoma

被引：2
|
作者：
Leiendecker, L. [1 ,2 ,3 ]
Jung, P. S. [1 ,2 ,3 ,4 ]
Obenauf, A. C. [1 ]
机构：
[1] Vienna BioCtr VBC, Res Inst Mol Pathol IMP, Campus Vienna BioCtr 1, A-1030 Vienna, Austria
[2] Univ Vienna, Doctoral Sch, Vienna BioCtr PhD Program, A-1030 Vienna, Austria
[3] Med Univ Vienna, A-1030 Vienna, Austria
[4] Med Univ Vienna, Dept Dermatol, Vienna, Austria
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2022年 / 186卷 / 02期
关键词：
D O I：
10.1111/bjd.20894
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：209 / 210
页数：2
相关论文
共 50 条
  • [1] CD56: a useful marker for diagnosing Merkel cell carcinoma
    Kurokawa, M
    Nabeshima, K
    Akiyama, Y
    Maeda, S
    Nishida, T
    Nakayama, F
    Amano, M
    Ogata, K
    Setoyama, M
    [J]. JOURNAL OF DERMATOLOGICAL SCIENCE, 2003, 31 (03) : 219 - 224
  • [2] Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors
    Shah, Manisha H.
    Lorigan, Paul
    O'Brien, Mary E. R.
    Fossella, Frank V.
    Moore, Kathleen N.
    Bhatia, Shailender
    Kirby, Maurice
    Woll, Penella J.
    [J]. INVESTIGATIONAL NEW DRUGS, 2016, 34 (03) : 290 - 299
  • [3] Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors
    Manisha H. Shah
    Paul Lorigan
    Mary E. R. O’Brien
    Frank V. Fossella
    Kathleen N. Moore
    Shailender Bhatia
    Maurice Kirby
    Penella J. Woll
    [J]. Investigational New Drugs, 2016, 34 : 290 - 299
  • [4] Development of an antibody-drug conjugate targeting TIM-1 for the treatment of ovarian and renal cell carcinoma
    Thomas, Lawrence J.
    Vitale, Laura
    O'Neill, Thomas
    Dolnick, Ree
    Wallace, Paul K.
    Minderman, Hans
    Gergel, Lauren E.
    Forsberg, Eric M.
    Boyer, James M.
    Storey, James R.
    Hammond, Russell A.
    Widger, Jennifer
    Sundarapandiyan, Karuna
    Crocker, Andrea
    Marsh, Henry C.
    Keler, Tibor
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [5] Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells
    Sherbenou, Daniel W.
    Aftab, Blake T.
    Su, Yang
    Behrens, Christopher R.
    Wiita, Arun
    Logan, Aaron C.
    Acosta-Alvear, Diego
    Hann, Byron C.
    Walter, Peter
    Shuman, Marc A.
    Wu, Xiaobo
    Atkinson, John P.
    Wolf, Jeffrey L.
    Martin, Thomas G.
    Liu, Bin
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (12): : 4640 - 4653
  • [6] Basal cell carcinoma: CD56 and cytokeratin 5/6 staining patterns in the differential diagnosis with Merkel cell carcinoma
    Panse, Gauri
    McNiff, Jennifer M.
    Ko, Christine J.
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2017, 44 (06) : 553 - 556
  • [7] Targeting DLK1, a Notch ligand, with an antibody-drug conjugate in adrenocortical carcinoma
    Sun, Nai-Yun
    Kumar, Suresh
    Weiner, Amber
    Kim, Yoo Sun
    Mendoza, Arnulfo
    Nguyen, Rosa
    Okada, Reona
    Pommier, Yves
    Martinez, Dan
    Pogoriler, Jennifer
    Diskin, Sharon
    Maris, John
    Del Rivero, Jaydira
    Roper, Nitin
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [8] Targeting the TFE3 pathway in translocation renal cell carcinoma with the antibody-drug conjugate Glembatumumab vedotin
    Lang, M.
    Wei, D.
    Gibbs, B. K.
    Ohanjanian, L.
    Ricketts, C. J.
    Sourbier, C.
    Schmidt, L. S.
    Linehan, W. M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2018, 103 : E132 - E132
  • [9] An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer
    Jacob, Joan
    Francisco, Liezl E.
    Chatterjee, Treena
    Liang, Zhengdong
    Subramanian, Shraddha
    Liu, Qingyun J.
    Rowe, Julie H.
    Carmon, Kendra S.
    [J]. BRITISH JOURNAL OF CANCER, 2023, 128 (08) : 1592 - 1602
  • [10] Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models
    Whiteman, Kathleen R.
    Johnson, Holly A.
    Mayo, Michele F.
    Audette, Charlene A.
    Carrigan, Christina N.
    LaBelle, Alyssa
    Zukerberg, Lawrence
    Lambert, John M.
    Lutz, Robert J.
    [J]. MABS, 2014, 6 (02) : 556 - 566
12345